- Dr P V Ap­paji, Di­rec­tor Gen­eral Emer­i­tus, PHARMEXCIL

BioSpectrum (India) - - COVER STORY -

“Multi­na­tional com­pa­nies in In­dia have stopped man­u­fac­tur­ing some of their prod­ucts and have out­sourced to In­dian man­u­fac­tur­ers. Prod­ucts which are brand lead­ers in its seg­ments are also be­ing out­sourced to many In­dian com­pa­nies and yet re­tain­ing their mar­ket share. The ris­ing cost of man­u­fac­tur­ing and some of the age­ing plants of Europe reach­ing their life cy­cle con­clu­sion may open up enor­mous op­por­tu­ni­ties to In­dia’s com­pa­nies in con­tract man­u­fac­tur­ing as Euro­pean com­pa­nies are also con­sid­er­ing to ei­ther re­lo­cate those units in cost ef­fi­cient cen­tres like In­dia or to out­source to In­dia man­u­fac­tur­ers. The con­tract man­u­fac­tur­ing space in In­dia is ex­pected to gain grounds in the near fu­ture. The ef­fi­ciency in man­u­fac­tur­ing and ma­tu­rity of busi­ness mod­els would even­tu­ally lead to con­tain­ment of cost of man­u­fac­tur­ing to a great ex­tent.”

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.